Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals
We aimed to identify cerebrospinal fluid (CSF) biomarkers associated with neurodegeneration in individuals with and without CSF evidence of Alzheimer pathology. We investigated 287 Alzheimer’s Disease Neuroimaging Initiative (ADNI) subjects (age=74.9±6.9; 22/48/30% with Alzheimer’s disease/mild cogn...
Saved in:
| Published in | Translational psychiatry Vol. 4; no. 7; p. e419 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
29.07.2014
Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2158-3188 2158-3188 |
| DOI | 10.1038/tp.2014.58 |
Cover
Loading…
| Abstract | We aimed to identify cerebrospinal fluid (CSF) biomarkers associated with neurodegeneration in individuals with and without CSF evidence of Alzheimer pathology. We investigated 287 Alzheimer’s Disease Neuroimaging Initiative (ADNI) subjects (age=74.9±6.9; 22/48/30% with Alzheimer’s disease/mild cognitive impairment/controls) with CSF multiplex analyte data and serial volumetric MRI. We calculated brain and hippocampal atrophy rates, ventricular expansion and Mini Mental State Examination decline. We used false discovery rate corrected regression analyses to assess associations between CSF variables and atrophy rates in individuals with and without amyloid pathology, adjusting in stages for tau, baseline volume, p-tau, age, sex, ApoE4 status and diagnosis. Analytes showing statistically significant independent relationships were entered into reverse stepwise analyses. Adjusting for tau, baseline volume, p-tau, age, sex and ApoE4, 4/83 analytes were significantly independently associated with brain atrophy rate, 1/83 with ventricular expansion and 2/83 with hippocampal atrophy. The strongest CSF predictor for the three atrophy measures was low trefoil factor 3 (TFF3). High cystatin C (CysC) was associated with higher whole brain atrophy and hippocampal atrophy rates. Lower levels of vascular endothelial growth factor and chromogranin A (CrA) were associated with higher whole brain atrophy. In exploratory reverse stepwise analyses, lower TFF3 was associated with higher rates of whole brain, hippocampal atrophy and ventricular expansion. Lower levels of CrA were associated with higher whole brain atrophy rate. The relationship between low TFF3 and increased hippocampal atrophy rate remained after adjustment for diagnosis. We identified a series of CSF markers that are independently associated with rate of neurodegeneration in amyloid-positive individuals. TFF3, a substrate for NOTCH processing may be an important biomarker of neurodegeneration across the Alzheimer spectrum. |
|---|---|
| AbstractList | We aimed to identify cerebrospinal fluid (CSF) biomarkers associated with neurodegeneration in individuals with and without CSF evidence of Alzheimer pathology. We investigated 287 Alzheimer's Disease Neuroimaging Initiative (ADNI) subjects (age=74.9±6.9; 22/48/30% with Alzheimer's disease/mild cognitive impairment/controls) with CSF multiplex analyte data and serial volumetric MRI. We calculated brain and hippocampal atrophy rates, ventricular expansion and Mini Mental State Examination decline. We used false discovery rate corrected regression analyses to assess associations between CSF variables and atrophy rates in individuals with and without amyloid pathology, adjusting in stages for tau, baseline volume, p-tau, age, sex, ApoE4 status and diagnosis. Analytes showing statistically significant independent relationships were entered into reverse stepwise analyses. Adjusting for tau, baseline volume, p-tau, age, sex and ApoE4, 4/83 analytes were significantly independently associated with brain atrophy rate, 1/83 with ventricular expansion and 2/83 with hippocampal atrophy. The strongest CSF predictor for the three atrophy measures was low trefoil factor 3 (TFF3). High cystatin C (CysC) was associated with higher whole brain atrophy and hippocampal atrophy rates. Lower levels of vascular endothelial growth factor and chromogranin A (CrA) were associated with higher whole brain atrophy. In exploratory reverse stepwise analyses, lower TFF3 was associated with higher rates of whole brain, hippocampal atrophy and ventricular expansion. Lower levels of CrA were associated with higher whole brain atrophy rate. The relationship between low TFF3 and increased hippocampal atrophy rate remained after adjustment for diagnosis. We identified a series of CSF markers that are independently associated with rate of neurodegeneration in amyloid-positive individuals. TFF3, a substrate for NOTCH processing may be an important biomarker of neurodegeneration across the Alzheimer spectrum. We aimed to identify cerebrospinal fluid (CSF) biomarkers associated with neurodegeneration in individuals with and without CSF evidence of Alzheimer pathology. We investigated 287 Alzheimer's Disease Neuroimaging Initiative (ADNI) subjects (age = 74.9 +/- 6.9; 22/48/30% with Alzheimer's disease/mild cognitive impairment/controls) with CSF multiplex analyte data and serial volumetric MRI. We calculated brain and hippocampal atrophy rates, ventricular expansion and Mini Mental State Examination decline. We used false discovery rate corrected regression analyses to assess associations between CSF variables and atrophy rates in individuals with and without amyloid pathology, adjusting in stages for tau, baseline volume, p-tau, age, sex, ApoE4 status and diagnosis. Analytes showing statistically significant independent relationships were entered into reverse stepwise analyses. Adjusting for tau, baseline volume, p-tau, age, sex and ApoE4, 4/83 analytes were significantly independently associated with brain atrophy rate, 1/83 with ventricular expansion and 2/83 with hippocampal atrophy. The strongest CSF predictor for the three atrophy measures was low trefoil factor 3 (TFF3). High cystatin C (CysC) was associated with higher whole brain atrophy and hippocampal atrophy rates. Lower levels of vascular endothelial growth factor and chromogranin A (CrA) were associated with higher whole brain atrophy. In exploratory reverse stepwise analyses, lower TFF3 was associated with higher rates of whole brain, hippocampal atrophy and ventricular expansion. Lower levels of CrA were associated with higher whole brain atrophy rate. The relationship between low TFF3 and increased hippocampal atrophy rate remained after adjustment for diagnosis. We identified a series of CSF markers that are independently associated with rate of neurodegeneration in amyloid-positive individuals. TFF3, a substrate for NOTCH processing may be an important biomarker of neurodegeneration across the Alzheimer spectrum. We aimed to identify cerebrospinal fluid (CSF) biomarkers associated with neurodegeneration in individuals with and without CSF evidence of Alzheimer pathology. We investigated 287 Alzheimer's Disease Neuroimaging Initiative (ADNI) subjects (age=74.9±6.9; 22/48/30% with Alzheimer's disease/mild cognitive impairment/controls) with CSF multiplex analyte data and serial volumetric MRI. We calculated brain and hippocampal atrophy rates, ventricular expansion and Mini Mental State Examination decline. We used false discovery rate corrected regression analyses to assess associations between CSF variables and atrophy rates in individuals with and without amyloid pathology, adjusting in stages for tau, baseline volume, p-tau, age, sex, ApoE4 status and diagnosis. Analytes showing statistically significant independent relationships were entered into reverse stepwise analyses. Adjusting for tau, baseline volume, p-tau, age, sex and ApoE4, 4/83 analytes were significantly independently associated with brain atrophy rate, 1/83 with ventricular expansion and 2/83 with hippocampal atrophy. The strongest CSF predictor for the three atrophy measures was low trefoil factor 3 (TFF3). High cystatin C (CysC) was associated with higher whole brain atrophy and hippocampal atrophy rates. Lower levels of vascular endothelial growth factor and chromogranin A (CrA) were associated with higher whole brain atrophy. In exploratory reverse stepwise analyses, lower TFF3 was associated with higher rates of whole brain, hippocampal atrophy and ventricular expansion. Lower levels of CrA were associated with higher whole brain atrophy rate. The relationship between low TFF3 and increased hippocampal atrophy rate remained after adjustment for diagnosis. We identified a series of CSF markers that are independently associated with rate of neurodegeneration in amyloid-positive individuals. TFF3, a substrate for NOTCH processing may be an important biomarker of neurodegeneration across the Alzheimer spectrum.We aimed to identify cerebrospinal fluid (CSF) biomarkers associated with neurodegeneration in individuals with and without CSF evidence of Alzheimer pathology. We investigated 287 Alzheimer's Disease Neuroimaging Initiative (ADNI) subjects (age=74.9±6.9; 22/48/30% with Alzheimer's disease/mild cognitive impairment/controls) with CSF multiplex analyte data and serial volumetric MRI. We calculated brain and hippocampal atrophy rates, ventricular expansion and Mini Mental State Examination decline. We used false discovery rate corrected regression analyses to assess associations between CSF variables and atrophy rates in individuals with and without amyloid pathology, adjusting in stages for tau, baseline volume, p-tau, age, sex, ApoE4 status and diagnosis. Analytes showing statistically significant independent relationships were entered into reverse stepwise analyses. Adjusting for tau, baseline volume, p-tau, age, sex and ApoE4, 4/83 analytes were significantly independently associated with brain atrophy rate, 1/83 with ventricular expansion and 2/83 with hippocampal atrophy. The strongest CSF predictor for the three atrophy measures was low trefoil factor 3 (TFF3). High cystatin C (CysC) was associated with higher whole brain atrophy and hippocampal atrophy rates. Lower levels of vascular endothelial growth factor and chromogranin A (CrA) were associated with higher whole brain atrophy. In exploratory reverse stepwise analyses, lower TFF3 was associated with higher rates of whole brain, hippocampal atrophy and ventricular expansion. Lower levels of CrA were associated with higher whole brain atrophy rate. The relationship between low TFF3 and increased hippocampal atrophy rate remained after adjustment for diagnosis. We identified a series of CSF markers that are independently associated with rate of neurodegeneration in amyloid-positive individuals. TFF3, a substrate for NOTCH processing may be an important biomarker of neurodegeneration across the Alzheimer spectrum. |
| Author | Schott, J M Paterson, R W Zetterberg, H Trojanowski, J Q Fox, N C Shaw, L M Blennow, K Bartlett, J W |
| Author_xml | – sequence: 1 givenname: R W surname: Paterson fullname: Paterson, R W organization: Department of Neurodegeneration, Dementia Research Centre, UCL Institute of Neurology – sequence: 2 givenname: J W surname: Bartlett fullname: Bartlett, J W organization: Department of Medical Statistics, London School of Hygiene and Tropical Medicine – sequence: 3 givenname: K surname: Blennow fullname: Blennow, K organization: Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden – sequence: 4 givenname: N C surname: Fox fullname: Fox, N C organization: Department of Neurodegeneration, Dementia Research Centre, UCL Institute of Neurology – sequence: 6 givenname: L M surname: Shaw fullname: Shaw, L M organization: Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA – sequence: 7 givenname: J Q surname: Trojanowski fullname: Trojanowski, J Q organization: Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA – sequence: 8 givenname: H surname: Zetterberg fullname: Zetterberg, H organization: Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK – sequence: 9 givenname: J M surname: Schott fullname: Schott, J M email: j.schott@ucl.ac.uk organization: Department of Neurodegeneration, Dementia Research Centre, UCL Institute of Neurology |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25072324$$D View this record in MEDLINE/PubMed https://gup.ub.gu.se/publication/208290$$DView record from Swedish Publication Index |
| BookMark | eNptkl1rHCEUhqWkNGmam_6AMtCb0jJbdcbVuSmUJf2AQG_aa3H1zMR0VqfqbAj0x-ekuymbtIIcPT7n5ejrc3IUYgBCXjK6YLRR78u04JS1C6GekBPOhKobptTRwfqYnOV8RXGIVjHJnpFjLqjkDW9PyO8VJFinmCcfzFj14-xdtTHpJ6Rc-WDH2fkwVCVBHz2eG1tiqprKJKhMztF6U8BV175cVgHmFB0MECCZ4mNAgcpsbsboXT3F7IvfAuac33o3mzG_IE97DHC2j6fkx6fz76sv9cW3z19XHy9q2ypa6qXlIBgXTsiubzoHsu1V2zOxdJIaSi3n0lHBrOqUbZa0X_adU8ysHe5Adc0pqXe6-Rqmea2n5PGKNzoar4d50pgaZp1Bc6p4R5H_sOMR3oCzEEoy44OyhyfBX-ohbnXLWMe5QIE3e4EUf82Qi974bGEcTYA4Z82EoFQKKVtEXz9Cr-Kc0AukZMcYxymRenXY0d9W7o1EgO4Ai15mdEtbX_6YgA36UTOq776LLpO--y5aKCx5-6jkXvW_8Lv9EyIUBkgHbf5L3wK91dGg |
| CitedBy_id | crossref_primary_10_1016_j_neurobiolaging_2021_04_025 crossref_primary_10_3233_JAD_191153 crossref_primary_10_3390_ijms20174149 crossref_primary_10_1016_j_neulet_2018_09_055 crossref_primary_10_1016_j_ymeth_2020_04_008 crossref_primary_10_14336_AD_2017_0416 crossref_primary_10_1038_ncomms7760 crossref_primary_10_3389_fneur_2015_00256 crossref_primary_10_1016_j_euroneuro_2019_11_002 crossref_primary_10_1016_j_neurobiolaging_2015_03_001 crossref_primary_10_2147_NDT_S252008 crossref_primary_10_3390_ijms161226105 crossref_primary_10_1016_j_neuropharm_2022_109335 crossref_primary_10_1038_s41419_022_04504_6 crossref_primary_10_1007_s00726_015_1938_9 crossref_primary_10_1016_j_jalz_2016_11_007 crossref_primary_10_1002_hbm_25800 crossref_primary_10_1038_tp_2016_194 crossref_primary_10_3390_ijms22094909 crossref_primary_10_1093_brain_awae034 crossref_primary_10_3390_ijms252111663 crossref_primary_10_1371_journal_pone_0134368 crossref_primary_10_1007_s13311_023_01370_8 crossref_primary_10_1080_01621459_2022_2087658 crossref_primary_10_1016_j_isci_2023_108526 crossref_primary_10_3389_fphar_2022_903099 crossref_primary_10_1016_j_ajhg_2020_10_001 crossref_primary_10_1186_s40035_021_00263_0 crossref_primary_10_1080_13803395_2022_2115015 crossref_primary_10_3233_JAD_160477 crossref_primary_10_1093_ijnp_pyaa046 crossref_primary_10_1016_j_jalz_2015_05_003 crossref_primary_10_3390_jcm8050651 crossref_primary_10_15789_2220_7619_2019_1_39_46 crossref_primary_10_1002_trc2_12018 crossref_primary_10_1515_bmc_2015_0020 crossref_primary_10_1038_s41398_018_0183_x |
| Cites_doi | 10.1016/j.bbr.2011.10.051 10.1016/j.neurobiolaging.2013.02.003 10.1038/srep02053 10.1038/tp.2013.69 10.1001/archneur.64.8.1130 10.1016/S0140-6736(04)15441-X 10.1016/j.peptides.2004.01.020 10.1016/S1474-4422(06)70355-6 10.1212/01.wnl.0000167542.89697.0f 10.1096/fasebj.10.13.8940297 10.1371/journal.pone.0058816 10.1212/01.wnl.0000304041.09418.b1 10.1016/j.neurobiolaging.2013.08.027 10.1016/S0166-4328(01)00297-2 10.1111/j.1471-4159.2012.07826.x 10.1212/WNL.52.8.1687 10.1212/01.WNL.0000110315.26026.EF 10.1017/S104161029700433X 10.1016/j.neuroimage.2010.03.018 10.1016/j.clinthera.2012.01.022 10.1007/s00415-006-0173-4 10.1016/S0197-4580(01)00285-8 10.1109/42.640753 10.2217/bmm.12.42 10.1038/nrneurol.2010.4 10.1016/S1474-4422(12)70291-0 10.1016/S1474-4422(03)00530-1 10.3389/fnmol.2012.00079 10.1016/j.jalz.2013.04.334 10.1002/jmri.21049 10.1016/0306-9877(95)90228-7 10.1016/S0140-6736(03)14469-8 10.1002/ana.21610 10.1016/S1474-4422(13)70044-9 10.1016/j.neurobiolaging.2010.04.011 10.1111/j.2517-6161.1964.tb00553.x |
| ContentType | Journal Article |
| Contributor | Jack, Jr, Clifford R Khachaturian, Zaven Vemuri, Prashanthi Figurski, Michal Schuff, Norbert Snyder, Peter Schwartz, Adam Frank, Richard Chen, Kewei Jagust, William Jiminez, Gus Green, Robert C Mesulam, M Marcel Pawluczyk, Sonia Weiner, Michael Borowski, Bret Hefti, Franz Montine, Tom Dolen, Sara Gunter, Jeff Thompson, Paul DeCArli, Charles Trojanowki, John Q Fox, Nick Thal, Lean Faber, Kelley Lind, Betty Korecka, Magdalena Walter, Sarah Quinn, Joseph Fillit, Howard Neu, Scott Sather, Tamie Jones, David Landau, Susan Paul, Steven Kantarci, Kejal Aisen, Paul Morris, John Holtzman, Davie Reiman, Eric M Buckholtz, Neil Morris, John C Foster, Norm Householder, Erin Mathis, Chet Foroud, Tatiana M Kaye, Jeffrey Saykin, Andrew J Harvey, Danielle Koeppe, Robert A Weiner, Michael W Nho, Kwangsik Potkin, Steven Potter, William Gessert, Devon Petersen, Ronald Shaw, Leslie M Donohue, Michael Schneider, Lon S Sorensen, Greg Thomas, Ronald G Raichle, Marc Davies, Peter Ward, Chad Hsiao, John Shen, Li Senjem, Matt Albert, Marylyn Kim, Sungeun Carter, Raina Carrillo, Mar |
| Contributor_xml | – sequence: 1 givenname: Michael W surname: Weiner fullname: Weiner, Michael W – sequence: 2 givenname: Paul surname: Aisen fullname: Aisen, Paul – sequence: 3 givenname: Michael surname: Weiner fullname: Weiner, Michael – sequence: 4 givenname: Ronald surname: Petersen fullname: Petersen, Ronald – sequence: 5 givenname: Clifford R surname: Jack, Jr fullname: Jack, Jr, Clifford R – sequence: 6 givenname: William surname: Jagust fullname: Jagust, William – sequence: 7 givenname: John Q surname: Trojanowki fullname: Trojanowki, John Q – sequence: 8 givenname: Arthur W surname: Toga fullname: Toga, Arthur W – sequence: 9 givenname: Laurel surname: Beckett fullname: Beckett, Laurel – sequence: 10 givenname: Robert C surname: Green fullname: Green, Robert C – sequence: 11 givenname: Andrew J surname: Saykin fullname: Saykin, Andrew J – sequence: 12 givenname: John surname: Morris fullname: Morris, John – sequence: 13 givenname: Leslie M surname: Shaw fullname: Shaw, Leslie M – sequence: 14 givenname: Zaven surname: Khachaturian fullname: Khachaturian, Zaven – sequence: 15 givenname: Greg surname: Sorensen fullname: Sorensen, Greg – sequence: 16 givenname: Maria surname: Carrillo fullname: Carrillo, Maria – sequence: 17 givenname: Lew surname: Kuller fullname: Kuller, Lew – sequence: 18 givenname: Marc surname: Raichle fullname: Raichle, Marc – sequence: 19 givenname: Steven surname: Paul fullname: Paul, Steven – sequence: 20 givenname: Peter surname: Davies fullname: Davies, Peter – sequence: 21 givenname: Howard surname: Fillit fullname: Fillit, Howard – sequence: 22 givenname: Franz surname: Hefti fullname: Hefti, Franz – sequence: 23 givenname: Davie surname: Holtzman fullname: Holtzman, Davie – sequence: 24 givenname: M Marcel surname: Mesulam fullname: Mesulam, M Marcel – sequence: 25 givenname: William surname: Potter fullname: Potter, William – sequence: 26 givenname: Peter surname: Snyder fullname: Snyder, Peter – sequence: 27 givenname: Adam surname: Schwartz fullname: Schwartz, Adam – sequence: 28 givenname: Tom surname: Montine fullname: Montine, Tom – sequence: 29 givenname: Ronald G surname: Thomas fullname: Thomas, Ronald G – sequence: 30 givenname: Michael surname: Donohue fullname: Donohue, Michael – sequence: 31 givenname: Sarah surname: Walter fullname: Walter, Sarah – sequence: 32 givenname: Devon surname: Gessert fullname: Gessert, Devon – sequence: 33 givenname: Tamie surname: Sather fullname: Sather, Tamie – sequence: 34 givenname: Gus surname: Jiminez fullname: Jiminez, Gus – sequence: 35 givenname: Danielle surname: Harvey fullname: Harvey, Danielle – sequence: 36 givenname: Matthew surname: Bernstein fullname: Bernstein, Matthew – sequence: 37 givenname: Nick surname: Fox fullname: Fox, Nick – sequence: 38 givenname: Paul surname: Thompson fullname: Thompson, Paul – sequence: 39 givenname: Norbert surname: Schuff fullname: Schuff, Norbert – sequence: 40 givenname: Charles surname: DeCArli fullname: DeCArli, Charles – sequence: 41 givenname: Bret surname: Borowski fullname: Borowski, Bret – sequence: 42 givenname: Jeff surname: Gunter fullname: Gunter, Jeff – sequence: 43 givenname: Matt surname: Senjem fullname: Senjem, Matt – sequence: 44 givenname: Prashanthi surname: Vemuri fullname: Vemuri, Prashanthi – sequence: 45 givenname: David surname: Jones fullname: Jones, David – sequence: 46 givenname: Kejal surname: Kantarci fullname: Kantarci, Kejal – sequence: 47 givenname: Chad surname: Ward fullname: Ward, Chad – sequence: 48 givenname: Robert A surname: Koeppe fullname: Koeppe, Robert A – sequence: 49 givenname: Norm surname: Foster fullname: Foster, Norm – sequence: 50 givenname: Eric M surname: Reiman fullname: Reiman, Eric M – sequence: 51 givenname: Kewei surname: Chen fullname: Chen, Kewei – sequence: 52 givenname: Chet surname: Mathis fullname: Mathis, Chet – sequence: 53 givenname: Susan surname: Landau fullname: Landau, Susan – sequence: 54 givenname: John C surname: Morris fullname: Morris, John C – sequence: 55 givenname: Nigel J surname: Cairns fullname: Cairns, Nigel J – sequence: 56 givenname: Erin surname: Householder fullname: Householder, Erin – sequence: 57 givenname: Lisa surname: Taylor-Reinwald fullname: Taylor-Reinwald, Lisa – sequence: 58 givenname: Virginia surname: Lee fullname: Lee, Virginia – sequence: 59 givenname: Magdalena surname: Korecka fullname: Korecka, Magdalena – sequence: 60 givenname: Michal surname: Figurski fullname: Figurski, Michal – sequence: 61 givenname: Karen surname: Crawford fullname: Crawford, Karen – sequence: 62 givenname: Scott surname: Neu fullname: Neu, Scott – sequence: 63 givenname: Tatiana M surname: Foroud fullname: Foroud, Tatiana M – sequence: 64 givenname: Steven surname: Potkin fullname: Potkin, Steven – sequence: 65 givenname: Li surname: Shen fullname: Shen, Li – sequence: 66 givenname: Kelley surname: Faber fullname: Faber, Kelley – sequence: 67 givenname: Sungeun surname: Kim fullname: Kim, Sungeun – sequence: 68 givenname: Kwangsik surname: Nho fullname: Nho, Kwangsik – sequence: 69 givenname: Lean surname: Thal fullname: Thal, Lean – sequence: 70 givenname: Leon surname: Thal fullname: Thal, Leon – sequence: 71 givenname: Neil surname: Buckholtz fullname: Buckholtz, Neil – sequence: 72 givenname: Peter J surname: Snyder fullname: Snyder, Peter J – sequence: 73 givenname: Marylyn surname: Albert fullname: Albert, Marylyn – sequence: 74 givenname: Richard surname: Frank fullname: Frank, Richard – sequence: 75 givenname: John surname: Hsiao fullname: Hsiao, John – sequence: 76 givenname: Jeffrey surname: Kaye fullname: Kaye, Jeffrey – sequence: 77 givenname: Joseph surname: Quinn fullname: Quinn, Joseph – sequence: 78 givenname: Betty surname: Lind fullname: Lind, Betty – sequence: 79 givenname: Raina surname: Carter fullname: Carter, Raina – sequence: 80 givenname: Sara surname: Dolen fullname: Dolen, Sara – sequence: 81 givenname: Lon S surname: Schneider fullname: Schneider, Lon S – sequence: 82 givenname: Sonia surname: Pawluczyk fullname: Pawluczyk, Sonia |
| Copyright | The Author(s) 2014 Copyright Nature Publishing Group Jul 2014 Copyright © 2014 Macmillan Publishers Limited 2014 Macmillan Publishers Limited |
| Copyright_xml | – notice: The Author(s) 2014 – notice: Copyright Nature Publishing Group Jul 2014 – notice: Copyright © 2014 Macmillan Publishers Limited 2014 Macmillan Publishers Limited |
| CorporateAuthor | Alzheimer's Disease Neuroimaging Initiative |
| CorporateAuthor_xml | – name: Alzheimer's Disease Neuroimaging Initiative |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTPV AOWAS F1U |
| DOI | 10.1038/tp.2014.58 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Göteborgs universitet |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Trefoil factor 3 predicts neurodegeneration rate |
| EISSN | 2158-3188 |
| EndPage | e419 |
| ExternalDocumentID | oai_gup_ub_gu_se_208290 PMC4119225 4067032661 25072324 10_1038_tp_2014_58 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NCATS NIH HHS grantid: UL1 TR001108 – fundername: NIA NIH HHS grantid: U24 AG021886 – fundername: NIA NIH HHS grantid: P30 AG013846 – fundername: NIA NIH HHS grantid: P30 AG010129 – fundername: NIBIB NIH HHS grantid: P41 EB015922 – fundername: NIA NIH HHS grantid: U01 AG024904 – fundername: NIA NIH HHS grantid: K01 AG030514 – fundername: NCATS NIH HHS grantid: UL1 TR002529 – fundername: NCATS NIH HHS grantid: TL1 TR000096 |
| GroupedDBID | --- 0R~ 3V. 4.4 53G 5VS 7X7 88E 8FI 8FJ AAJSJ AAKDD ABUWG ACGFO ACGFS ACMJI ACSMW ADBBV ADFRT AENEX AFKRA AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EJD EMOBN FYUFA GROUPED_DOAJ GX1 HMCUK HYE KQ8 LGEZI LOTEE M1P M~E NADUK NAO NXXTH OK1 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT UKHRP AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS PUEGO 7X8 5PM ADTPV AOWAS F1U |
| ID | FETCH-LOGICAL-c480t-6c2e5125d579f39de74f84f156d70a00c227d051c898c360f6f9d81abdc36e893 |
| IEDL.DBID | AAJSJ |
| ISSN | 2158-3188 |
| IngestDate | Thu Aug 21 06:45:02 EDT 2025 Thu Aug 21 18:25:41 EDT 2025 Thu Sep 04 18:25:47 EDT 2025 Sat Aug 23 14:13:05 EDT 2025 Thu Apr 03 07:05:24 EDT 2025 Thu Apr 24 22:59:39 EDT 2025 Tue Jul 01 00:55:00 EDT 2025 Fri Feb 21 02:38:56 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| License | This work is licensed under a Creative Commons Attribution 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c480t-6c2e5125d579f39de74f84f156d70a00c227d051c898c360f6f9d81abdc36e893 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Members of the Alzheimer's Disease Neuroimaging Initiative Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf Members of the Alzheimer's Disease Neuroimaging Initiative are listed before References. |
| OpenAccessLink | https://www.nature.com/articles/tp.2014.58 |
| PMID | 25072324 |
| PQID | 1791129117 |
| PQPubID | 2041978 |
| ParticipantIDs | swepub_primary_oai_gup_ub_gu_se_208290 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4119225 proquest_miscellaneous_1550075774 proquest_journals_1791129117 pubmed_primary_25072324 crossref_citationtrail_10_1038_tp_2014_58 crossref_primary_10_1038_tp_2014_58 springer_journals_10_1038_tp_2014_58 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-07-29 |
| PublicationDateYYYYMMDD | 2014-07-29 |
| PublicationDate_xml | – month: 07 year: 2014 text: 2014-07-29 day: 29 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: United States |
| PublicationTitle | Translational psychiatry |
| PublicationTitleAbbrev | Transl Psychiatry |
| PublicationTitleAlternate | Transl Psychiatry |
| PublicationYear | 2014 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Villemagne, Burnham, Bourgeat, Brown, Ellis, Salvado (CR25) 2013; 12 Shaw, Vanderstichele, Knapik-Czajka, Clark, Aisen, Petersen (CR11) 2009; 65 Jack, Shiung, Gunter, O’Brien, Weigand, Knopman (CR23) 2004; 62 Kauwe, Bailey, Ridge, Cruchaga, Foutz, Perry (CR12) 2013; 9 Fox, Scahill, Crum, Rossor (CR7) 1999; 52 Blennow, Davidsson, Wallin, Ekman (CR39) 1995; 6 Shi, Yin, Song, Guo, Luo (CR30) 2012; 227 McLarnon (CR36) 2012; 1 Klipper-Aurbach, Wasserman, Braunspiegel-Weintrob (CR19) 1995; 45 Fagan, Perrin (CR38) 2012; 6 CR31 Hansson, Zetterberg, Buchhave, Londos, Blennow, Minthon (CR9) 2006; 5 Box, Cox (CR14) 1964; 26 Schott, Frost, Whitwell, Macmanus, Boyes, Rossor (CR1) 2006; 253 Jack, Bernstein, Fox, Thompson, Alexander, Harvey (CR15) 2008; 27 Jack, Knopman, Jagust, Petersen, Weiner, Aisen (CR21) 2013; 12 Fox, Schott (CR22) 2004; 363 Hinz, Schwegler, Chwieralski, Laube, Linke, Pohle (CR29) 2004; 25 Mattsson, Insel, Nosheny, Zetterberg, Trojanowski, Shaw (CR13) 2013; 3 Leung, Barnes, Ridgway, Bartlett, Clarkson, Macdonald (CR17) 2010; 51 Probst, Zetzsche, Weber, Theilemann, Skutella, Landgraf (CR28) 1996; 10 Freeborough, Fox (CR16) 1997; 16 Schott, Price, Frost, Whitwell, Rossor, Fox (CR18) 2005; 65 Dutta, Barber, Zhang, Doperalski, Liu (CR34) 2012; 122 Schott, Bartlett, Barnes, Leung, Ourselin, Fox (CR6) 2010; 31 Religa, Cao, Religa, Xue, Bogdanovic, Westaway (CR35) 2013; 3 Blennow, Hampel, Weiner, Zetterberg (CR8) 2010; 6 Andrews, Modat, Macdonald, Yeatman, Cardoso, Leung (CR24) 2013; 8 Kaur, Levy (CR33) 2012; 5 Chan, Janssen, Whitwell, Watt, Jenkins, Frost (CR3) 2003; 362 Josephs, Whitwell, Knopman, Hu, Stroh, Baker (CR5) 2008; 70 Mattsson, Insel, Nosheny, Trojanowski, Shaw, Jack (CR10) 2014; 35 Benjamini, Drai, Elmer, Kafkafi, Golani (CR20) 2001; 125 Woo, Kim, Lee (CR2) 1997; 9 Blennow, Hampel (CR27) 2003; 2 Barnes, Carmichael, Leung, Schwarz, Ridgway, Bartlett (CR4) 2013; 34 Whitwell, Petersen, Negash, Weigand, Kantarci, Ivnik (CR26) 2007; 64 Tong, Wang, Sverdlov, Huang, Slemmon, Croop (CR32) 2012; 34 Tarkowski, Issa, Sjogren, Wallin, Blennow, Tarkowski (CR37) 2002; 23 BFtp201458_CR31 J Kauwe (BFtp201458_CR12) 2013; 9 JL Whitwell (BFtp201458_CR26) 2007; 64 M Hinz (BFtp201458_CR29) 2004; 25 KA Andrews (BFtp201458_CR24) 2013; 8 KK Leung (BFtp201458_CR17) 2010; 51 HS Shi (BFtp201458_CR30) 2012; 227 G Kaur (BFtp201458_CR33) 2012; 5 P Religa (BFtp201458_CR35) 2013; 3 VL Villemagne (BFtp201458_CR25) 2013; 12 E Tarkowski (BFtp201458_CR37) 2002; 23 O Hansson (BFtp201458_CR9) 2006; 5 N Mattsson (BFtp201458_CR10) 2014; 35 JM Schott (BFtp201458_CR18) 2005; 65 PA Freeborough (BFtp201458_CR16) 1997; 16 JI Woo (BFtp201458_CR2) 1997; 9 J Barnes (BFtp201458_CR4) 2013; 34 KA Josephs (BFtp201458_CR5) 2008; 70 CR Jack Jr. (BFtp201458_CR23) 2004; 62 NC Fox (BFtp201458_CR7) 1999; 52 NC Fox (BFtp201458_CR22) 2004; 363 K Blennow (BFtp201458_CR8) 2010; 6 LM Shaw (BFtp201458_CR11) 2009; 65 D Chan (BFtp201458_CR3) 2003; 362 Y Benjamini (BFtp201458_CR20) 2001; 125 G Tong (BFtp201458_CR32) 2012; 34 K Blennow (BFtp201458_CR39) 1995; 6 CR Jack Jr (BFtp201458_CR15) 2008; 27 CR Jack Jr (BFtp201458_CR21) 2013; 12 N Mattsson (BFtp201458_CR13) 2013; 3 Y Klipper-Aurbach (BFtp201458_CR19) 1995; 45 K Blennow (BFtp201458_CR27) 2003; 2 JM Schott (BFtp201458_CR1) 2006; 253 G Dutta (BFtp201458_CR34) 2012; 122 GEP Box (BFtp201458_CR14) 1964; 26 JC Probst (BFtp201458_CR28) 1996; 10 AM Fagan (BFtp201458_CR38) 2012; 6 JM Schott (BFtp201458_CR6) 2010; 31 JG McLarnon (BFtp201458_CR36) 2012; 1 |
| References_xml | – volume: 227 start-page: 265 year: 2012 end-page: 269 ident: CR30 article-title: Neuropeptide Trefoil factor 3 improves learning and retention of novel object recognition memory in mice publication-title: Behav Brain Res doi: 10.1016/j.bbr.2011.10.051 – volume: 34 start-page: 1996 year: 2013 end-page: 2002 ident: CR4 article-title: Vascular and Alzheimer’s disease markers independently predict brain atrophy rate in Alzheimer’s Disease Neuroimaging Initiative controls publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2013.02.003 – volume: 26 start-page: 211 year: 1964 end-page: 252 ident: CR14 article-title: An analysis of transformations publication-title: J Roy Stat Soc B – volume: 3 start-page: 2053 year: 2013 ident: CR35 article-title: VEGF significantly restores impaired memory behavior in Alzheimer’s mice by improvement of vascular survival publication-title: Sci Rep doi: 10.1038/srep02053 – volume: 3 start-page: e293 year: 2013 ident: CR13 article-title: CSF protein biomarkers predicting longitudinal reduction of CSF beta-amyloid42 in cognitively healthy elders publication-title: Transl Psychiatry doi: 10.1038/tp.2013.69 – volume: 64 start-page: 1130 year: 2007 end-page: 1138 ident: CR26 article-title: Patterns of atrophy differ among specific subtypes of mild cognitive impairment publication-title: Arch Neurol doi: 10.1001/archneur.64.8.1130 – volume: 363 start-page: 392 year: 2004 end-page: 394 ident: CR22 article-title: Imaging cerebral atrophy: normal ageing to Alzheimer's disease publication-title: Lancet doi: 10.1016/S0140-6736(04)15441-X – volume: 25 start-page: 827 year: 2004 end-page: 832 ident: CR29 article-title: Trefoil factor family (TFF) expression in the mouse brain and pituitary: changes in the developing cerebellum publication-title: Peptides doi: 10.1016/j.peptides.2004.01.020 – volume: 5 start-page: 228 year: 2006 end-page: 234 ident: CR9 article-title: Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: a follow-up study publication-title: Lancet Neurol doi: 10.1016/S1474-4422(06)70355-6 – volume: 65 start-page: 119 year: 2005 end-page: 124 ident: CR18 article-title: Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months publication-title: Neurology doi: 10.1212/01.wnl.0000167542.89697.0f – volume: 10 start-page: 1518 year: 1996 end-page: 1523 ident: CR28 article-title: Human intestinal trefoil factor is expressed in human hypothalamus and pituitary: evidence for a novel neuropeptide publication-title: FASEB J doi: 10.1096/fasebj.10.13.8940297 – volume: 8 start-page: e58816 year: 2013 ident: CR24 article-title: Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials publication-title: PloS One doi: 10.1371/journal.pone.0058816 – volume: 6 start-page: 306 year: 1995 end-page: 311 ident: CR39 article-title: Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer’s disease? publication-title: Dementia – volume: 70 start-page: 1850 year: 2008 end-page: 1857 ident: CR5 article-title: Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype publication-title: Neurology doi: 10.1212/01.wnl.0000304041.09418.b1 – volume: 35 start-page: 614 year: 2014 end-page: 622 ident: CR10 article-title: Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2013.08.027 – volume: 125 start-page: 279 year: 2001 end-page: 284 ident: CR20 article-title: Controlling the false discovery rate in behavior genetics research publication-title: Behav Brain Res doi: 10.1016/S0166-4328(01)00297-2 – volume: 122 start-page: 752 year: 2012 end-page: 763 ident: CR34 article-title: Involvement of dopaminergic neuronal cystatin C in neuronal injury-induced microglial activation and neurotoxicity publication-title: J Neurochem doi: 10.1111/j.1471-4159.2012.07826.x – volume: 52 start-page: 1687 year: 1999 end-page: 1689 ident: CR7 article-title: Correlation between rates of brain atrophy and cognitive decline in AD publication-title: Neurology doi: 10.1212/WNL.52.8.1687 – volume: 62 start-page: 591 year: 2004 end-page: 600 ident: CR23 article-title: Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD publication-title: Neurology doi: 10.1212/01.WNL.0000110315.26026.EF – volume: 9 start-page: 183 year: 1997 end-page: 196 ident: CR2 article-title: Age of onset and brain atrophy in Alzheimer's disease publication-title: Int Psychogeriatr doi: 10.1017/S104161029700433X – volume: 51 start-page: 1345 year: 2010 end-page: 1359 ident: CR17 article-title: Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease publication-title: Neuroimage. doi: 10.1016/j.neuroimage.2010.03.018 – volume: 34 start-page: 654 year: 2012 end-page: 667 ident: CR32 article-title: Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral gamma-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers publication-title: Clin Ther doi: 10.1016/j.clinthera.2012.01.022 – volume: 253 start-page: 1147 year: 2006 end-page: 1153 ident: CR1 article-title: Combining short interval MRI in Alzheimer’s disease: implications for therapeutic trials publication-title: J Neurol doi: 10.1007/s00415-006-0173-4 – volume: 23 start-page: 237 year: 2002 end-page: 243 ident: CR37 article-title: Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer’s disease and vascular dementia publication-title: Neurobiol Aging doi: 10.1016/S0197-4580(01)00285-8 – volume: 16 start-page: 623 year: 1997 end-page: 629 ident: CR16 article-title: The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI publication-title: IEEE Trans Med Imaging doi: 10.1109/42.640753 – volume: 6 start-page: 455 year: 2012 end-page: 476 ident: CR38 article-title: Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease publication-title: Biomark Med doi: 10.2217/bmm.12.42 – volume: 6 start-page: 131 year: 2010 end-page: 144 ident: CR8 article-title: Cerebrospinal fluid and plasma biomarkers in Alzheimer disease publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2010.4 – volume: 12 start-page: 207 year: 2013 end-page: 216 ident: CR21 article-title: Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers publication-title: Lancet Neurol doi: 10.1016/S1474-4422(12)70291-0 – volume: 2 start-page: 605 year: 2003 end-page: 613 ident: CR27 article-title: CSF markers for incipient Alzheimer's disease publication-title: Lancet Neurol doi: 10.1016/S1474-4422(03)00530-1 – ident: CR31 – volume: 1 start-page: 199 year: 2012 end-page: 204 ident: CR36 article-title: Microglial chemotactic signaling factors in Alzheimer's disease publication-title: Am J Neurodegener Dis – volume: 5 start-page: 79 year: 2012 ident: CR33 article-title: Cystatin C in Alzheimer's disease publication-title: Front Mol Neurosci doi: 10.3389/fnmol.2012.00079 – volume: 9 start-page: 677 year: 2013 end-page: 678 ident: CR12 article-title: Association of genetic variants with cerebrospinal fluid protein levels of ACE, MMP3 and other proteins and risk for Alzheimer’s disease publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2013.04.334 – volume: 27 start-page: 685 year: 2008 end-page: 691 ident: CR15 article-title: The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods publication-title: J Magn Reson Imaging doi: 10.1002/jmri.21049 – volume: 45 start-page: 486 year: 1995 end-page: 490 ident: CR19 article-title: Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus publication-title: Med Hypotheses doi: 10.1016/0306-9877(95)90228-7 – volume: 362 start-page: 1121 year: 2003 end-page: 1122 ident: CR3 article-title: Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study publication-title: Lancet doi: 10.1016/S0140-6736(03)14469-8 – volume: 65 start-page: 403 year: 2009 end-page: 413 ident: CR11 article-title: Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects publication-title: Ann Neurol doi: 10.1002/ana.21610 – volume: 12 start-page: 357 year: 2013 end-page: 367 ident: CR25 article-title: Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study publication-title: Lancet Neurol doi: 10.1016/S1474-4422(13)70044-9 – volume: 31 start-page: 1452 year: 2010 end-page: 1462 ident: CR6 article-title: Reduced sample sizes for atrophy outcomes in Alzheimer’s disease trials: baseline adjustment publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2010.04.011 – volume: 5 start-page: 228 year: 2006 ident: BFtp201458_CR9 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(06)70355-6 – volume: 3 start-page: 2053 year: 2013 ident: BFtp201458_CR35 publication-title: Sci Rep doi: 10.1038/srep02053 – volume: 23 start-page: 237 year: 2002 ident: BFtp201458_CR37 publication-title: Neurobiol Aging doi: 10.1016/S0197-4580(01)00285-8 – volume: 6 start-page: 131 year: 2010 ident: BFtp201458_CR8 publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2010.4 – volume: 6 start-page: 306 year: 1995 ident: BFtp201458_CR39 publication-title: Dementia – volume: 1 start-page: 199 year: 2012 ident: BFtp201458_CR36 publication-title: Am J Neurodegener Dis – volume: 9 start-page: 183 year: 1997 ident: BFtp201458_CR2 publication-title: Int Psychogeriatr doi: 10.1017/S104161029700433X – volume: 51 start-page: 1345 year: 2010 ident: BFtp201458_CR17 publication-title: Neuroimage. doi: 10.1016/j.neuroimage.2010.03.018 – volume: 35 start-page: 614 year: 2014 ident: BFtp201458_CR10 publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2013.08.027 – volume: 10 start-page: 1518 year: 1996 ident: BFtp201458_CR28 publication-title: FASEB J doi: 10.1096/fasebj.10.13.8940297 – volume: 65 start-page: 403 year: 2009 ident: BFtp201458_CR11 publication-title: Ann Neurol doi: 10.1002/ana.21610 – volume: 65 start-page: 119 year: 2005 ident: BFtp201458_CR18 publication-title: Neurology doi: 10.1212/01.wnl.0000167542.89697.0f – volume: 45 start-page: 486 year: 1995 ident: BFtp201458_CR19 publication-title: Med Hypotheses doi: 10.1016/0306-9877(95)90228-7 – volume: 2 start-page: 605 year: 2003 ident: BFtp201458_CR27 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(03)00530-1 – volume: 70 start-page: 1850 year: 2008 ident: BFtp201458_CR5 publication-title: Neurology doi: 10.1212/01.wnl.0000304041.09418.b1 – volume: 363 start-page: 392 year: 2004 ident: BFtp201458_CR22 publication-title: Lancet doi: 10.1016/S0140-6736(04)15441-X – volume: 25 start-page: 827 year: 2004 ident: BFtp201458_CR29 publication-title: Peptides doi: 10.1016/j.peptides.2004.01.020 – volume: 34 start-page: 654 year: 2012 ident: BFtp201458_CR32 publication-title: Clin Ther doi: 10.1016/j.clinthera.2012.01.022 – volume: 362 start-page: 1121 year: 2003 ident: BFtp201458_CR3 publication-title: Lancet doi: 10.1016/S0140-6736(03)14469-8 – volume: 227 start-page: 265 year: 2012 ident: BFtp201458_CR30 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2011.10.051 – volume: 5 start-page: 79 year: 2012 ident: BFtp201458_CR33 publication-title: Front Mol Neurosci doi: 10.3389/fnmol.2012.00079 – volume: 253 start-page: 1147 year: 2006 ident: BFtp201458_CR1 publication-title: J Neurol doi: 10.1007/s00415-006-0173-4 – volume: 122 start-page: 752 year: 2012 ident: BFtp201458_CR34 publication-title: J Neurochem doi: 10.1111/j.1471-4159.2012.07826.x – volume: 3 start-page: e293 year: 2013 ident: BFtp201458_CR13 publication-title: Transl Psychiatry doi: 10.1038/tp.2013.69 – volume: 27 start-page: 685 year: 2008 ident: BFtp201458_CR15 publication-title: J Magn Reson Imaging doi: 10.1002/jmri.21049 – volume: 125 start-page: 279 year: 2001 ident: BFtp201458_CR20 publication-title: Behav Brain Res doi: 10.1016/S0166-4328(01)00297-2 – volume: 12 start-page: 207 year: 2013 ident: BFtp201458_CR21 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(12)70291-0 – volume: 52 start-page: 1687 year: 1999 ident: BFtp201458_CR7 publication-title: Neurology doi: 10.1212/WNL.52.8.1687 – volume: 6 start-page: 455 year: 2012 ident: BFtp201458_CR38 publication-title: Biomark Med doi: 10.2217/bmm.12.42 – volume: 31 start-page: 1452 year: 2010 ident: BFtp201458_CR6 publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2010.04.011 – volume: 64 start-page: 1130 year: 2007 ident: BFtp201458_CR26 publication-title: Arch Neurol doi: 10.1001/archneur.64.8.1130 – volume: 8 start-page: e58816 year: 2013 ident: BFtp201458_CR24 publication-title: PloS One doi: 10.1371/journal.pone.0058816 – volume: 62 start-page: 591 year: 2004 ident: BFtp201458_CR23 publication-title: Neurology doi: 10.1212/01.WNL.0000110315.26026.EF – volume: 26 start-page: 211 year: 1964 ident: BFtp201458_CR14 publication-title: J Roy Stat Soc B doi: 10.1111/j.2517-6161.1964.tb00553.x – volume: 9 start-page: 677 year: 2013 ident: BFtp201458_CR12 publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2013.04.334 – ident: BFtp201458_CR31 – volume: 12 start-page: 357 year: 2013 ident: BFtp201458_CR25 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(13)70044-9 – volume: 34 start-page: 1996 year: 2013 ident: BFtp201458_CR4 publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2013.02.003 – volume: 16 start-page: 623 year: 1997 ident: BFtp201458_CR16 publication-title: IEEE Trans Med Imaging doi: 10.1109/42.640753 |
| SSID | ssj0000548171 |
| Score | 2.230779 |
| Snippet | We aimed to identify cerebrospinal fluid (CSF) biomarkers associated with neurodegeneration in individuals with and without CSF evidence of Alzheimer... |
| SourceID | swepub pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e419 |
| SubjectTerms | 631/378/1689/364 692/53 692/699/375/132/1283 Aged Aged, 80 and over Alzheimer Disease - cerebrospinal fluid Alzheimer Disease - pathology Amyloidosis - cerebrospinal fluid Amyloidosis - pathology Apolipoprotein E4 - cerebrospinal fluid Atrophy Behavioral Sciences BETA Biological Psychology BIOMARKERS Biomarkers - cerebrospinal fluid Brain - pathology BRAIN ATROPHY CEREBRAL ATROPHY Cerebral Ventricles - pathology Cognitive Dysfunction - cerebrospinal fluid Cognitive Dysfunction - pathology Cystatin C - cerebrospinal fluid Female Hippocampus - pathology Humans INCIPIENT ALZHEIMERS-DISEASE Male Medicine & Public Health Mental Status Schedule MILD COGNITIVE IMPAIRMENT MRI NEUROPEPTIDE Neurosciences Neurovetenskaper Original original-article Peptides - cerebrospinal fluid Pharmacotherapy Psychiatry RATES Statistics as Topic tau Proteins - cerebrospinal fluid Trefoil Factor-3 |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELaglRAXBOXRQKmMqJA4hOZhx_YJoapVhVROVNqb5djOEmmbXTYJJ348M86DLq047nrkdXbGnm9mnG8IOVEevJopXGyNKLHMyOOS5XnsLBfeZIlhBt93vvpWXF6zrwu-GBNu7XitcjoTw0Ht1hZz5KdIowm-KU3F583PGLtGYXV1bKHxkOwH6jKwZ7EQc44F4IhMRTqxkubytEOKypR9wg7vt_3QHXB5947kXCj9h1Q0OKKLp-TJiCDpl0Hlz8gD3xyQR1djjfw5-X3mtxDoYj8QlKtWfe3oDd7C2ba0buyqR3dFO1jSuobx0HCH5tRsPTWjsryjmKClge3S-WXgpkYVwgTU3ECQX7t4uO_1y9N6fqmrfUGuL86_n13GY4-F2DKZdHFhMw8-nzsuVJUr5wWrJKsgqnMiMUlis0w42LhWKmnzIqmKSjmZmtLBJw9g5yXZa9aNPyTUQWTluKoAg3hmSq48OD8muFGKgd5cRD5O_7i2IwE59sFY6VAIz6XuNhq1o7mMyPtZdjPQbtwrdTQpTo9br9V_DSUi7-Zh2DRYCTGNX_cgA3EZYCWAvhF5Neh5_hnAhAJhZkTEjgXMAkjIvTvS1D8CMTcDI4TzMSInk63cWtY9q_8w2NHOzMt-o-GrZa9bD5JY5379_8d8Qx7jjJhwztQR2eu2vX8LSKkrj8N2-AOVDxf6 priority: 102 providerName: ProQuest |
| Title | Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals |
| URI | https://link.springer.com/article/10.1038/tp.2014.58 https://www.ncbi.nlm.nih.gov/pubmed/25072324 https://www.proquest.com/docview/1791129117 https://www.proquest.com/docview/1550075774 https://pubmed.ncbi.nlm.nih.gov/PMC4119225 https://gup.ub.gu.se/publication/208290 |
| Volume | 4 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEB6aDZReSt91ky4qDYUe3PohWdJxuySEhYTSNrA3IVvy1rDxLmu7p_74jPwim-SQk21pLAuP5PlGM_4EcCItWjWdGD_TPHVhRuanNI59kzFudRRoqt3_zheXyfkVXSzZsqfJqfq0yo7Ssv1MD9lh32vHLRnSb0wcwKFAsxdN4HA2W_xejCsqCD5EyMOBgzQWt27atzr3oOT9jMgxLHqHQrQ1O2cv4HmPF8ms6-FLeGLLV_D0oo-Iv4b_c7tDt9bt_uHk8nVTGHLtcm52FSnKbN0440Rq7NKmwPp2ex0SE72zRPeqsYa45VjSclsau2qZqJ3CsAGir9GlL4zfZXf9s6QYf-Gq3sDV2emf-bnf76jgZ1QEtZ9kkUULzwzjMo-lsZzmgubowxke6CDIoogbnKaZkCKLkyBPcmlEqFODVxahzVuYlJvSvgdi0I8yTOaIOCzVKZMWTR3lTEtJ8QNqPPg6vHGV9XTjbteLtWrD3rFQ9VY57SgmPPg8ym47ko0HpY4Hxal-olXKsasiZAlD7sGnsRqniIt76NJuGpRBLwyREQJdD951eh4fgwiQO1DpAd8bAaOAo9_erymLvy0NNw0RHUfMg5NhrNzq1gO9_9KNo72WV81WYdGqUZVFSRfV_vC49o7gmTtzy8yRPIZJvWvsR8RHdTqFA77k03564PHH6eXPX1g6T-bTds3hBlFpGIA |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VWwm4oPIOLWBEQeIQmocTJweEoLTa0u4KoVbqLTixs0TaJssmAVXiN_EbmcmLLq249Zj1yPHGnz2fPfY3ANuhRq8mfWUmUsQUZvTMmLuuqRJPaOlYkku67zyZ-uMT_unUO12D3_1dGDpW2c-JzUStioT2yHdIRhN9k22Ld4vvJmWNouhqn0KjhcWhPv-JS7by7cFH7N-XjrO_d7w7NrusAmbCA6sy_cTR6OU85YkwdUOlBU8DnuI6RglLWlbiOEIhVJMgDBLXt1I_DVVgy1jhkw5IfAmn_HVON1pHsP5hb_r5y7CrgwQosIXd66C6wU5Fopg2f0M55S96vkt09vKpzCE0-4-MaeP69jfgdsdZ2fsWZHdgTed34caki8rfg1-7eolLa8pAQnbpvM4UO6NzP8uSZXkyr8lBsgqbVGRY3qT4YS6TS81kBw-tGG0Js0ZfU-lZo4ZNoMEKmDw7nxeZMtsTZj80y4ZrZOV9OLmW7_8ARnmR60fAFK7llBemyHo0l7EXanS3XHgyDDkiRRnwuv_iUdJJnlPmjXnUhN7dIKoWEfVO5AUGvBhsF63Qx5VWW33HRd1gL6O_0DTg-VCMw5RiLzLXRY02uBJEdoZk24CHbT8Pr0EWKojYGiBWEDAYkAT4akmefWukwLmNDN3xDNjusXKhWVe0_lWLo5WaZ_Uiwp9mdVRqtKTI-uP__81ncHN8PDmKjg6mh5twi2qn7W4n3IJRtaz1E-RpVfy0GxwMvl73ePwDLGVVfw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIlVcEG8CBYwoSBzC5mHH9gEh1LJqKa04UGlvwYmdbaRtsmwSUCV-Gb-Ombzo0opbj1mPHG884_nGY39DyI6y4NV0ZNxUiwTTjNxNWBi6JuXC6sDTTON956PjaP-EfZrx2Qb5PdyFwWOVw5rYLtSmTHGPfII0muCbfF9Msv5YxJe96fvldxcrSGGmdSin0anIoT3_CeFb9e5gD-b6VRBMP37d3Xf7CgNuyqRXu1EaWPB43HChslAZK1gmWQYxjRGe9rw0CIQBtU2lkmkYeVmUKSN9nRh4shKJmGD5vyFCQFVgS2Imxv0dgELSF_7AiBrKSY30mD57i9XlL_rAS8D28vnMMUn7D6Fp6wSnt8mtHr3SD5263SEbtrhLto76_Pw98mvXriDIxlokKJctmtzQMzwBtKpoXqSLBl0lrWFIZQ7tbbEfGlK9slT3imINxc1h2jJtGjtvebFRfaADqs_OF2Vu3O6s2Q9L8_FCWXWfnFzL139ANouysI8INRDVGa4ywD-W6YQrC46XCa6VYqAzxiFvhi8epz35OdbgWMRtEj6Ucb2McXZiLh3ycpRddpQfV0ptDxMX92ZfxX-V1CEvxmYwWMzC6MKWDchATAg4DWC3Qx528zy-BvCoQIjrELGmAaMAkoGvtxT5aUsKznzA6gF3yM6gKxeGdcXoX3d6tNbzvFnG8NO8iSsLkphjf_z_v_mcbIEVxp8Pjg-fkJvYOe57B2qbbNarxj4FwFYnz1rLoOTbdZviH-iIWEY |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cerebrospinal+fluid+markers+including+trefoil+factor+3+are+associated+with+neurodegeneration+in+amyloid-positive+individuals&rft.jtitle=Translational+psychiatry&rft.au=Paterson%2C+R+W&rft.au=Bartlett%2C+J+W&rft.au=Blennow%2C+K&rft.au=Fox%2C+N+C&rft.date=2014-07-29&rft.pub=Nature+Publishing+Group&rft.eissn=2158-3188&rft.volume=4&rft.issue=7&rft.spage=e419&rft_id=info:doi/10.1038%2Ftp.2014.58&rft_id=info%3Apmid%2F25072324&rft.externalDocID=PMC4119225 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2158-3188&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2158-3188&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2158-3188&client=summon |